Detalhe da pesquisa
1.
First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 39(2): 145-154, 2021 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301375
2.
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.
Oncotarget
; 9(17): 13366-13381, 2018 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568363
3.
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
N Engl J Med
; 351(4): 337-45, 2004 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15269313
4.
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
J Clin Oncol
; 23(24): 5568-77, 2005 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16009950
5.
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
J Clin Oncol
; 22(1): 175-84, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14701780
6.
Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.
Radiother Oncol
; 76(2): 162-7, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16024114
7.
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
J Clin Oncol
; 24(18): 2866-72, 2006 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16717293
8.
New systemic frontline treatment for metastatic colorectal carcinoma.
Cancer
; 100(8): 1558-77, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15073842